Newsfeeds - Spark Newswire

2 minute read

Ginkgo Bioworks Announces Proposed Public Offering $100M Of Class A Common Stock

Today, 12:40 PM

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ("Ginkgo"),which is building the leading platform for cell programing and biosecurity, today announced that it intends to offer and sell $100 million of its

DNA

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 12:40 PM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

2 minute read

Ginkgo Bioworks And The Ministry Of Investment Of Saudi Arabia Announce Plans To Develop Biosecurity And Biotechnology Capabilities For Global Public Health

By Benzinga Newsdesk

Today, 12:40 PM

Collaboration aims to bolster capabilities of key public health and research institutions, launch new biosecurity initiatives, and drive the development of the bioeconomy BOSTON and RIYADH, Saudi

DNA

2 minute read

Morgan Stanley, First Republic Bank And Other Big Losers From Friday

By Lisa Levin

Today, 12:40 PM

U.S. stocks closed lower on Friday, with the Dow Jones dropping over 400 points. Here is the list of some big stocks recording losses in the previous session.

ACMR

1 minute read

Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing

By Vandana Singh

Today, 12:40 PM

Ginkgo Bioworks Holdings Inc (NYSE:DNA) collaborated with Merck & Co Inc (NYSE:MRK) to engineer up to four enzymes for use as biocatalysts in…

DNA

1 minute read

Morgan Stanley Initiates Coverage On Ginkgo Bioworks Holdings with Equal-Weight Rating, Announces Price Target of $5

By Benzinga Newsdesk

Today, 12:40 PM

Morgan Stanley analyst Tejas Savant initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Equal-Weight rating and announces Price Target of $5.

DNA

5 minute read

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:40 PM

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.

ABOS

2 minute read

Netflix, Biogen And Other Big Gainers From Wednesday

By Lisa Levin

Today, 12:40 PM

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

ABOS